XML 36 R7.htm IDEA: XBRL DOCUMENT v3.25.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Treasury Stock
Additional Paid-In Capital
Retained Deficit
Accumulated Other Comprehensive Loss
Beginning Balance (in shares) at Dec. 31, 2022   32,826,852        
Beginning balance at Dec. 31, 2022 $ 120,040 $ 328 $ (14,514) $ 261,371 $ (95,595) $ (31,550)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of restricted stock (in shares)   730,291        
Issuance of restricted stock 7 $ 7        
Surrender of common stock by employees (in shares)   (234,608)        
Surrender of common stock by employees (1,638) $ (2) (1,636)      
Share-based compensation expense 3,846     3,846    
Net income (loss) from continuing operations for the period 43,633       43,633  
Net income from discontinued operation for the period 5,778       5,778  
Total comprehensive income (loss) 1,266         1,266
Ending balance (in shares) at Dec. 31, 2023   33,322,535        
Ending balance at Dec. 31, 2023 172,932 $ 333 (16,150) 265,217 (46,184) (30,284)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of restricted stock (in shares)   489,562        
Issuance of restricted stock 4 $ 4        
Surrender of common stock by employees (in shares)   (117,701)        
Surrender of common stock by employees (318) $ 0 (318)      
Share-based compensation expense 3,900     3,900    
Net income (loss) from continuing operations for the period (35,734)       (35,734)  
Net income from discontinued operation for the period 7,867       7,867  
Total comprehensive income (loss) $ (13,059)         (13,059)
Ending balance (in shares) at Dec. 31, 2024 33,694,396 33,694,396        
Ending balance at Dec. 31, 2024 $ 135,592 $ 337 (16,468) 269,117 (74,051) (43,343)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of restricted stock (in shares)   649,260        
Issuance of restricted stock 7 $ 7        
Surrender of common stock by employees (in shares)   (157,974)        
Surrender of common stock by employees (240) $ (2) (238)      
Share-based compensation expense 3,786     3,786    
Net income (loss) from continuing operations for the period (20,477)       (20,477)  
Net income from discontinued operation for the period (2,304)       (2,304)  
Total comprehensive income (loss) $ 16,993         16,993
Ending balance (in shares) at Dec. 31, 2025 34,185,682 34,185,682        
Ending balance at Dec. 31, 2025 $ 133,357 $ 342 $ (16,706) $ 272,903 $ (96,832) $ (26,350)